These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 15199435)
1. Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects. Pocovi M; Civeira F; Alonso R; Mata P Semin Vasc Med; 2004 Feb; 4(1):67-74. PubMed ID: 15199435 [TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
3. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. Civeira F; Ros E; Jarauta E; Plana N; Zambon D; Puzo J; Martinez de Esteban JP; Ferrando J; Zabala S; Almagro F; Gimeno JA; Masana L; Pocovi M Am J Cardiol; 2008 Nov; 102(9):1187-93, 1193.e1. PubMed ID: 18940289 [TBL] [Abstract][Full Text] [Related]
4. Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform. Alonso R; Defesche JC; Tejedor D; Castillo S; Stef M; Mata N; Gomez-Enterria P; Martinez-Faedo C; Forga L; Mata P Clin Biochem; 2009 Jun; 42(9):899-903. PubMed ID: 19318025 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening. Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915 [TBL] [Abstract][Full Text] [Related]
6. Application of molecular genetics for diagnosing familial hypercholesterolemia in Norway: results from a family-based screening program. Leren TP; Manshaus T; Skovholt U; Skodje T; Nossen IE; Teie C; Sørensen S; Bakken KS Semin Vasc Med; 2004 Feb; 4(1):75-85. PubMed ID: 15199436 [TBL] [Abstract][Full Text] [Related]
7. The molecular basis of familial hypercholesterolemia in The Netherlands. Fouchier SW; Defesche JC; Umans-Eckenhausen MW; Kastelein JP Hum Genet; 2001 Dec; 109(6):602-15. PubMed ID: 11810272 [TBL] [Abstract][Full Text] [Related]
8. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB). Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954 [TBL] [Abstract][Full Text] [Related]
9. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia. van Aalst-Cohen ES; Jansen AC; de Jongh S; de Sauvage Nolting PR; Kastelein JJ Semin Vasc Med; 2004 Feb; 4(1):31-41. PubMed ID: 15199431 [TBL] [Abstract][Full Text] [Related]
10. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting. Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590 [TBL] [Abstract][Full Text] [Related]
11. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia]. Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035 [TBL] [Abstract][Full Text] [Related]
12. Identification of recurrent and novel mutations in the LDL receptor gene in Spanish patients with familial hypercholesterolemia. Mutations in brief no. 135. Online. Cenarro A; Jensen HK; Casao E; Civeira F; González-Bonillo J; Rodríguez-Rey JC; Gregersen N; Pocoví M Hum Mutat; 1998; 11(5):413. PubMed ID: 10206683 [TBL] [Abstract][Full Text] [Related]
14. Update of the molecular basis of familial hypercholesterolemia in The Netherlands. Fouchier SW; Kastelein JJ; Defesche JC Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003 [TBL] [Abstract][Full Text] [Related]
15. Advanced method for the identification of patients with inherited hypercholesterolemia. Defesche JC; Lansberg PJ; Umans-Eckenhausen MA; Kastelein JJ Semin Vasc Med; 2004 Feb; 4(1):59-65. PubMed ID: 15199434 [TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR. Mozas P; Castillo S; Tejedor D; Reyes G; Alonso R; Franco M; Saenz P; Fuentes F; Almagro F; Mata P; Pocoví M Hum Mutat; 2004 Aug; 24(2):187. PubMed ID: 15241806 [TBL] [Abstract][Full Text] [Related]
17. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results. Bourbon M; Rato Q; Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457 [TBL] [Abstract][Full Text] [Related]
18. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Austin MA; Hutter CM; Zimmern RL; Humphries SE Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands. Wonderling D; Umans-Eckenhausen MA; Marks D; Defesche JC; Kastelein JJ; Thorogood M Semin Vasc Med; 2004 Feb; 4(1):97-104. PubMed ID: 15199439 [TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of familial hypercholesterolemia in Spain: Ten novel LDLR mutations and population analysis. García-García AB; Real JT; Puig O; Cebolla E; Marín-García P; Martínez Ferrandis JI; García-Sogo M; Civera M; Ascaso JF; Carmena R; Armengod ME; Chaves FJ Hum Mutat; 2001 Nov; 18(5):458-9. PubMed ID: 11668640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]